| MORPHOSYS AG O.N. | 127.9000 / -0.16% |
| Date/Time | 12/13 / 16:44 |
| Chg. / Chg.(%) | -0.2000 / -0.16% |
| Bid | 127.5000 / 100 |
| Ask | 128.2000 / 100 |
| Open | 128.6000 |
| Previous Close | 128.1000 |
| High | 130.1000 |
| Low | 127.2000 |
| Volume [EUR] | 163,559.9000 |
| Volume [Units] | 1,270 |
| Price fixings | 18 |
| ISIN | DE0006632003 |
| Security | MOR |
| Exchange | Frankfurt |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| Lang & Schwa.. | 127.700 |  |
|
| Xetra | 127.90 | |
217,540 |
| Cboe Europe .. | 127.80 | |
68,088 |
| Turquoise | 127.80 | |
67,750 |
| London Inter.. | 128.70 | |
25,219 |
| Cboe Europe .. | 127.70 | |
19,493 |
| TradeGate | 128.100 | |
11,757 |
| Stuttgart | 127.700 | |
3,218 |
| Frankfurt | 127.9000 | |
1,270 |
| München | 128.70 |  |
520 |
| Hamburg | 128.40 | |
40 |
| gettex | 128.000 | |
25 |
| Düsseldorf | 127.90 | |
21 |
| Vienna Globa.. | 127.90 | |
0 |
| Hannover | 128.50 | |
0 |
| Berlin | 128.50 | |
0 |
| SIX Swiss Ex.. | 102.00 | |
|
| Nasdaq Other.. | 138.0000 | 500 | |
| EUREX | Options | ||
News
- MOR106 clinical development in atopic dermatitis stopped for futility
10/28/2019 / 21:45 - GlobeNewswire - Galapagos and MorphoSys announce initiation of GECKO Phase 2 study with MOR106 in atopic dermatitis patients
04/23/2019 / 22:02 - GlobeNewswire - Galapagos and MorphoSys announce initiation of GECKO Phase 2 study with MOR106 in atopic dermatitis patients
04/23/2019 / 22:01 - GlobeNewswire - Galapagos and MorphoSys announce start of a Phase 1 subcutaneous bridging study with MOR106
09/13/2018 / 22:04 - GlobeNewswire - Galapagos and MorphoSys announce start of a Phase 1 subcutaneous bridging study with MOR106
09/13/2018 / 22:01 - GlobeNewswire
Real-time